Elwood & Goetz Wealth Advisory Group LLC Raises Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Elwood & Goetz Wealth Advisory Group LLC increased its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 51.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,164 shares of the company’s stock after purchasing an additional 1,070 shares during the quarter. Elwood & Goetz Wealth Advisory Group LLC’s holdings in Procter & Gamble were worth $548,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PG. Legal & General Group Plc increased its stake in Procter & Gamble by 0.6% in the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after purchasing an additional 122,190 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Procter & Gamble by 8.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after buying an additional 733,440 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Procter & Gamble by 9.7% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 6,161,507 shares of the company’s stock valued at $999,705,000 after acquiring an additional 545,601 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Procter & Gamble by 1.3% during the 1st quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock worth $974,914,000 after acquiring an additional 79,665 shares during the period. Finally, Canada Pension Plan Investment Board boosted its position in shares of Procter & Gamble by 3.9% in the second quarter. Canada Pension Plan Investment Board now owns 5,706,199 shares of the company’s stock worth $941,066,000 after acquiring an additional 216,300 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the sale, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 397,986 shares of company stock valued at $67,642,430. Insiders own 0.18% of the company’s stock.

Procter & Gamble Trading Down 0.8 %

Shares of PG opened at $168.22 on Friday. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The stock has a 50-day moving average price of $171.93 and a 200 day moving average price of $167.55. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The company has a market capitalization of $396.16 billion, a P/E ratio of 29.00, a P/E/G ratio of 3.67 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter last year, the company earned $1.83 earnings per share. Sell-side analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.39%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Wall Street Analysts Forecast Growth

PG has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. increased their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. DA Davidson boosted their price target on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. Morgan Stanley raised their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Stifel Nicolaus boosted their target price on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a report on Monday, July 22nd. Finally, Piper Sandler initiated coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.

Get Our Latest Report on Procter & Gamble

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.